Anna Wolters , Judith Reuther , Philipp Gude, Thomas Weber, Carsten TheissHeike Vogelsang, , Veronika Matschke
Abstract One of the major challenges in emergency medicine is out-of-hospital cardiac arrest (OHCA). Every year, about 53-62/100 000 people worldwide suffer an out-of-hospital cardiac arrest with serious consequences, whereas persistent brain injury is a major cause of morbidity and mortality of those surviving a cardiac arrest. Today, only few and insufficient strategies are known to limit neurological damage of ischemia and reperfusion injury. The aim of the present study was to investigate whether teriflunomide, an approved drug for treatment of relapsing-remitting-multiple-sclerosis, exerts a protective effect on brain cells in an in vitro model of ischemia. Therefore, organotypic slice cultures from rat hippocampus and cerebellum were exposed to oxygen-glucose-deprivation and subsequently treated with teriflunomide.The administration of teriflunomide in the reperfusion time on both hippocampal and cerebellar slice cultures significantly decreased the amount of detectable propidium iodide signal compared with an untreated culture, indicating that more cells survive after oxygen-glucosedeprivation. However, hippocampal slice cultures showed a higher vulnerability to ischemic conditions and a more sensitive response to teriflunomide compared with cerebellar slice cultures. Our study suggests that teriflunomide, applied as a post-treatment after an oxygenglucose-deprivation, has a protective effect on hippocampal and cerebellar cells in organotypic slice cultures of rats. All procedures were conducted under established standards of the German federal state of North Rhine Westphalia, in accordance with the European Communities Council Directive 2010/63/EU on the protection of animals used for scientific purposes.
Key Words: brain damage; cardiac arrest; cell death; hypoxic chamber; ischemia; organotypic slice cultures; post-treatment; resuscitation
Cardiac arrest is one of the major global health problems these days. It is estimated that the global incidence of suffering an out-of-hospital cardiac arrest (OHCA) is about 54/100,000 people per year (Berdowski et al., 2010; Myat et al., 2018). Despite worldwide programs for cardiopulmonary resuscitation of bystanders the prognosis of surviving an external heart attack remains low, with a global average survival rate of only 7% (Berdowski et al., 2010). A large number of patients surviving a cardiac arrest show severe neurological deficits, where mortality and morbidity after resuscitation mostly depend on the extent of brain injury(Arawwawala and Brett, 2007). Satisfying neurologic outcome is only seen in about 10% of surviving patients (Laver et al.,2004; Mozaffarian et al., 2015).
The brain is very vulnerable to hypoxic damage caused by circulatory arrest because energy reserves to maintain metabolism in poor circulation are very limited (Busl and Greer, 2010; Cronberg, 2017). The concentrations of essential energy sources decrease rapidly after onset of an ischemia causing an anoxic depolarization of the cell (Busl and Greer, 2010) leading to changes in the cellular electrolyte composition and thus a loss of ion gradient, local acidosis and excitotoxic glutamate release (Busl and Greer, 2010).Additionally, rapidly after onset of cardiac arrest, neural ischemic cell death is triggered by reactive oxygen species(ROS) accumulation (Bernard et al., 2002, 2010; Kongpolprom and Cholkraisuwat, 2019). After successful resuscitation and the return of spontaneous circulation, reperfusion injury boosts neuronal death by activating pro-inflammatory cascades leading to necrosis and apoptosis in the brain,inducing remote organ failure (Caplan, 1991; Piantadosi and Zhang, 1996; Busl and Greer, 2010; Minutoli et al., 2016;Cronberg, 2017; Sekhon et al., 2017).
The outcome of hypoxic brain damage is different for every individual and can range from asymptomatic to persistent vegetative states (Piantadosi and Zhang, 1996). One possible explanation is the fact that neurons in some brain areas are more resistant to hypoxic damage than others (Lipton,1999; Bernard et al., 2010). Neurons of the hippocampus are particularly susceptible to ischemia, followed by neurons of the cerebellum and other brain regions (Lipton, 1999).
Up to date there are no specific drug therapies for neuroprotection against ischemia and reperfusion injury,but there are many well-established drug therapies for the treatment of chronic inflammatory neurologic diseases. Since brain ischemia and reperfusion damage as well as chronic inflammatory diseases partly show common reactions,the question arises whether there is a drug for treatment of inflammatory neurological diseases that could also be beneficial after brain ischemia (Skaper et al., 2018).
Teriflunomide, an oral disease-modifying-therapy drug,integrated in the therapy of relapsing-remitting-multiplesclerosis (Scott, 2019), may have promising characteristics. The exact mechanism of the numerous effects of teriflunomide is not known yet, but there are several studies concerning leflunomide, being the active metabolite of teriflunomide,trying to elucidate its modes of action. It inhibits the mitochondrial enzyme dihydroorotate dehydrogenase, acts cytostatic to proliferating T- and B-lymphocytes, inhibits the cycloxygenase-2 and tumor necrosis factor-α-mediated nuclear factor kappa-light-chain-enhancer of activated B cellsactivation and thereby acts anti-inflammatory in different ways(Cherwinski et al., 1995; Bruneau et al., 1998; Hamilton et al.,1999; Ringheim et al., 2013; Bar-Or, 2014). Furthermore, pretreatment with teriflunomide diminished pro-inflammatory mediators in activated microglia and astrocytesin vitro(Edling et al., 2017).
Since teriflunomide offers the possibility of influencing inflammatory reactions, the question arises whether this drug can also contribute to alleviating cellular brain damage following ischemia. Therefore, the aim of this study was to investigate whether a post-treatment with teriflunomide has a protective effect on cerebellar and hippocampal slice cultures after oxygen-glucose-deprivation (OGD) as anin vitromodel of ischemia and reperfusion brain injury. A protective effect of teriflunomide could open up new possibilities to reduce the consequences of cardiac arrest on brain damage.
All procedures were conducted under established standards of the German federal state of North Rhine Westphalia, in accordance with the European Communities Council Directive 2010/63/EU on the protection of animals used for scientific purposes. According to current German and European legislation, the removal of organs or cells from vertebrates for scientific purposes is not considered an animal experiment if the animals have not been subject to surgical interventions or invasive treatments prior to sacrifice. Thus, euthanization of mice intended for the removal of brain tissue does not need an approval or permission by local or governmental authorities.
Organotypic slice cultures from cerebellum and hippocampus of wildtype Wistar rats were prepared, based on the method presented by Stoppini et al. (1991). Therefore, rat pups on their postnatal day 9 (p9) were decapitated, their brains explanted under sterile conditions and kept in Hanks Solution on ice. The cerebelli and the hippocampi of at least six rats of one litter were collected.
The cerebelli and hippocampi were cut into slices (275 µm thickness for cerebellum, 350 µm for hippocampus) by using a McIllwain Tissue Chopper and individually transferred onto Millicell Cell Culture Inserts (hydrophilic PTFE, pore size 0.4µm; #PICM0RG50, Merck, Darmstadt, Germany), which were preincubated with 1 mL cell culture medium in an incubator at 37°C and 5% CO2for 2 hours in six-well plates. Culture medium is based on Dulbeccos Modified Eagle Medium(DMEM; #A14430-01, Thermo Fisher Scientific, Waltham, MA,USA) supplemented with 25% heat-inactivated horse serum(#16050-122; Thermo Fisher Scientific), 25 mL Hanks Balanced Salts (NaCl 8 g/L, KCl 0.4 g/L, Na2HPO40.048 g/L, KH2PO40.06 g/L, CaCl2·2 H2O 0.185 g/L, MgSO40.098 g/L, NaHCO30.35 g/L,glucose 1 g/L), glucose 6.5 mg/mL, NGF 2.5 µg/mL (N-0513;Sigma-Aldrich, Darmstadt, Germany), GlutaMax 1 mL (#35050-061; Thermo Fisher Scientific), PenStrep 1 mL (penicillin 10,000 U, Streptomycin 10 mg; #P4333, Sigma-Aldrich) and Phenol Red 10 µg/mL (#P0290; Sigma-Aldrich).
These slices were cultured for 7 days, exchanging half of the cell culture medium for fresh culture medium every 48 hours.
After seven days in culture (7 div) an OGD was performed. For severely hypoxic conditions slice cultures were inserted into a humidified hypoxic chamber (Hypoxic Chamber Polymer O2Control Glove Box; Coy Lab, Grass Lake, MI, USA) at 37°C,< 0.4% O2, and 5% CO2. Cell culture medium was removed and replaced by glucose-free-OGD-medium, which has been pregassed for 2 hours in the hypoxic chamber. The cultures were exposed to OGD in the humidified hypoxic chamber for 30 minutes. The OGD was terminated by returning the cultures to an incubator with normoxic conditions (37°C, ~21% O2and 5% CO2) and fresh cell culture media, containing glucose(6.5 mg/mL). Propidium iodide (PI; 5 µg/mL; #P4170; Sigma-Aldrich) was added to the culture medium for identification of dead cells with a permeable membrane, serving as a marker for overall neuronal death. Control slices were kept under normoxic conditions in control-media containing glucose (6.5 mg/mL) at 37°C simultaneously.
Teriflunomide (#SML0936; Sigma-Aldrich) was stored as a stock solution of 50 mM dissolved in dimethyl-sulfoxide(DMSO; #7033; J.T.Baker, Fisher Scientific, Schwerte, Germany)at -20°C.
Teriflunomide was applied in different concentrations (1.25-25µM) directly after OGD in the reperfusion period to the culture medium along with glucose and PI. After 24 hours, the medium was switched to cold phosphate-buffered saline (PBS)before fixating the cultures with 4% paraformaldehyde in PBS for 20 minutes at room temperature. After fixation the slices were washed three times with PBS.
The following conditions were investigated in this study: 1)control w/o OGD, w/o treatment; 2) control w/o OGD, w/treatment (25 µM teriflunomide); 3) OGD w/o treatment; 4)OGD w/treatment (1.25-25 µM teriflunomide). Furthermore,it was investigated whether the solvent DMSO itself had an influence on the slice cultures under control or OGD conditions. Therefore, the cultures were incubated with the highest amount of DMSO (0.2%) after OGD or under control conditions as described above.
Every experiment was performed three times for each of the concentrations and conditions.
Slice cultures were stained with 4′,6-diamidin-2-phenylindol(DAPI; #9542, Sigma-Aldrich) for 30 minutes in the dark at room temperature and then washed three times with PBS.The slices were transferred on glass slides and mounted with Fluoroshield (#F6937, Sigma-Aldrich).
Analysis of the slices was performed using a confocal spinning disc microscope (VisiScope Confocal-Cell Explorer,Visitron Systems GmbH, Puchheim, Germany). Slices were viewed with an 20× objective (Nikon PlanFluor 20×, NA 0,5;Nikon Instruments Europe BV, Amsterdam, Netherlands)and captured in its entirety, including z-stacking, to analyze the total fluorescence of each slice. All images subjected to direct comparisons were taken at the same exposure and laser intensity. Total fluorescence values were measured and compared by using ImageJ software 1.51 s (National Institutes of Health, Bethesda, MD, USA). After obtaining the total fluorescence values for the two channels (PI and DAPI)of all samples, the ratio between PI and DAPI values was determined for each sample by dividing the intensity value of the PI channel by the intensity value of the corresponding DAPI channel. The values obtained were then normalized to the mean value of the OGD-condition without treatment with teriflunomide and displayed as percentage. To obtain the half-maximum effective concentration of teriflunomide,a non-linear regression was performed and the half maximal effective concentration (EC50) value was determined.
Statistical analyses of the date were performed as described previously (Röderer et al., 2018). In brief, data represent mean values of at least three independent experiments ± standard error of the mean (SEM). Data between two groups were tested for significance using a two-tailed Student’st-test and comparison among multiple groups were performed using one-way analysis of variance, while pairwise comparison within groups was performed by Tukey’s multiple comparisonspost hoctest. Results withP< 0.05 were considered statistically significant.
To investigate whether a 30-minute OGD causes cell death in hippocampal and cerebellar organotypic slice cultures,PI-positive cells were examined in the respective slice cultures. Cell death after an ischemic event of 30 minutes and subsequent 24-hour reperfusion was observed in the OGD group in both hippocampal and cerebellar slice cultures.The distribution pattern of dead cells showed up in the hippocampus mainly in CA1 and to a less extend in CA3 and in the cerebellum in form of diffuse cell nests, mainly located in the granular layer (GC), however a few positive signals were also found in molecular layer (Figure 1A and D). Interestingly,hippocampal slice cultures have shown cell death in CA1 even under control conditions (Figure 1A-C), whereas cerebellar cultures have not shown any PI positive signals under these conditions (Figure 1D-F). Looking at the identified cell death in hippocampal slice cultures, cell death after ODG is significantly (P< 0.0001) about 10 times higher than under control conditions (Figure 1C). Since no cell death can be observed in cerebellar slice cultures under control conditions,the cell death after OGD in this region is highly significant (P<0.0001) about 380 times higher (Figure 1F).
To investigate whether teriflunomide shows protective properties on hippocampal as well as cerebellar organotypic slice cultures after ischemic conditions, the drug was supplemented for 24 hours in the culture medium directly after OGD. Different concentrations (cerebellum 2.5, 7.5, 8.5,9.5, 10.5, 11.5, 12.5, and 25 µM; hippocampus: 1.25, 2.5, 4,5.5, 7.5, 8.5, 9.5, 10.5, 11.5, 12.5, and 25 µM) were used to determine the EC50of teriflunomide.
To describe the effect of teriflunomide on cell death the value of PI-intensity in the hippocampal cultures after OGD was set to 100%. A continuous decrease in the number of dead cells was observed especially in CA1 (Figure 2). The greatest effect on cell survival, measured in terms of the intensity of the PI signal, can already be observed at low concentrations (1.25-5µM) of teriflunomide (Figure 2C). When higher concentrations are applied, the effect on cell survival can only be seen to a small extent. A treatment with 25 µM teriflunomide reduced the PI-intensity nearly to control conditions to 13.72%. The calculated EC50value for the treatment of hippocampal OGDdamaged cells is 3.53 ± 0.14 µM (Figure 2C).
To describe the effect of teriflunomide on cell death in the cerebellar slice cultures the value of PI-intensity in the cerebellar cultures after OGD was set to 100%. A decrease in the intensity of PI-signal was observed in the labeling of cerebellar slice cultures mainly in GC layer (Figure 3).In contrast to the effect on hippocampal slice cultures,teriflunomide in low concentrations (2.5-7.5 µM) has almost negligible protective effect as measured by PI signal intensity in the examined cerebellar slice cultures after OGD. In the concentration range between 7.5 and 10.5 µM the protective effect of teriflunomide in cerebellar slice cultures following OGD is strongly evident. When using teriflunomide at a concentration of 12.5 µM, the PI signal intensity is almost reduced to the level of the control conditions (Figure 3C). The calculated EC50value for the treatment of cerebellar OGDdamaged cells is 9.22 ± 0.15 µM (Figure 3C).
The application of 0.2% DMSO alone in hippocampal as well as cerebellar slice cultures had no effect (Figures 2B and 3B). The application of 25 µM teriflunomide in control hippocampal as well as cerebellar slice cultures that did not receive OGD showed no differences compared to control conditions (Figures 2B and 3B). It can therefore be assumed that teriflunomide has not a cytotoxic or beneficial effect on the cultured cells under normoxic conditions.
In our study we implemented a model forin vitroischemia by combining organotypic slice cultures of the hippocampus and the cerebellum of the rat with a deprivation of oxygen and glucose (OGD), attempting to mimic anin vivobrain tissue reaction to ischemia.

Figure 1 |A 30-minute OGD induces identifiable cell death in hippocampal and cerebellar organotypic slice cultures.

Figure 2 |Protective effect of teriflunomide on cells of hippocampal organotypic slice cultures after 30-minutes of OGD.

Figure 3 |Protective effect of teriflunomide on cells of cerebellar organotypic slice cultures after 30-minutes of OGD.
Several studies showed that organotypic slice cultures are close toin vivotissue conditions (Fedoroff and Richardson,2001; Humpel, 2015; Li et al., 2016; Doussau et al., 2017),and thus allow experiments on cultures with a preserved three dimensional cytoarchitecture (Stoppini et al., 1991;Fedoroff and Richardson, 2001; Humpel, 2015; Li et al., 2016;Croft et al., 2019), retained neuronal networks (Fedoroff and Richardson, 2001; Humpel, 2015; Li et al., 2016) and upheld cell proportions (Stoppini et al., 1991; Fedoroff and Richardson, 2001; Li et al., 2016). Even small blood vessels e.g. capillaries can be kept in the tissue slice (Moser et al.,2003; Humpel, 2015). Dissociated cells lack integrity as well as complex contacts to each other, which does not depict the natural organism (Fedoroff and Richardson, 2001; Humpel,2015; Doussau et al., 2017; Croft et al., 2019). Therefore,organotypic slice cultures are more suitable than dissociated cells to investigate complex reactions. A limitation of our model, however, is that diapedesis cannot take place in this system either, since there is no functioning blood circulation as in the whole organismin vivo. Further OGD is a widely used and well-suited model to simulate ischemia (Goldberg and Choi, 1993; Strasser and Fischer, 1995; Tasca et al.,2015; Li et al., 2016; Ryou and Mallet, 2018), as they both present circumstances with interrupted supply of oxygen and nutrients. We performed an OGD duration of 30 minutes,since at higher incubation times the damage in the slice cultures was so severe that they were completely destroyed.The question remains open whether this time frame is sufficient to mimic decreased perfusion in living humans.
As cardiac arrests are still one of the major global health problems, leaving many survivors with severe neurological deficits (Busl and Greer, 2010; Sekhon et al.,2017; Welbourn and Efstathiou, 2018), we conducted experiments to contribute to the search for future therapy strategies. Therefore we focused on ischemic damage to the hippocampus and the cerebellum, as both tissue types show a particular susceptibility to hypoxic brain damagein vitromodels but alsoin vivoin humans (Björklund et al., 2014).There is no specific treatment available yet, which is able to show alleviation of brain damage after a cardiac arrest.Therefore, we searched for potential agents, which might help overcome cell death after ischemia. The study protocol was created in accordance with clinical conditions regarding doses and application time of teriflunomide. We started drug administration immediately after OGD, lasting for 24 hours. In case of clinical use, the emergency physician would also give the medication immediately after successful resuscitation as a posttreatment drug.
Since many studies showed an influence of teriflunomide - an anti-inflammatory drug - on neuronal structures as reviewed by Dekleijin et al. (2020), we considered this drug to be worth investigating if it might help to overcome cell death after ischemia.
Here, we show for the first time a beneficial effect of this compound on organotypic slice cultures after an oxygenglucose-deprivation by displaying a significant decrease in detectable PI-signal intensity, after application of the drug,compared to cultures subjected to OGD without a posttreatment. Interestingly the EC50values differ between the two brain regions, while the cells of the cerebellum need considerably more teriflunomide to reach its half maximal effect than those of the hippocampus [3.53 µM (hippocampus)vs. 9.22 µM (cerebellum)]. Furthermore, in ourin vitromodel of ischemia, we found that the hippocampus is much more vulnerable to OGD than the cerebellum. These findings are consistent with histological studies on brain tissue from patients who did not survive cardiac arrest (Björklund et al.,2014). Björklund et al. (2014) showed that the hippocampus is the most vulnerable brain region and exhibits more damage after cardiac arrest than other parts of the brain, including the cerebellum, which showed an intermediate vulnerability.Several studies found that patients surviving a cardiac arrest suffer from dysfunctions in long-term memory (Sulzgruber et al., 2015; Cronberg, 2017; Caro-Codón et al., 2018). This would be consistent to a possible hippocampal damage acquired during brain ischemia. As a limitation of our study,it must be mentioned that the slice thicknesses differed between the brain regions because of technical limitations.Hippocampal slices were thicker than cerebellar slices (275µm thickness for cerebellum, 350 µm for hippocampus).This may be of relevance since teriflunomide reached target cells by diffusion. A further limitation also results from the thicker hippocampal slices. Unfortunately, the thickness of the hippocampal slice cultures does not allow complete immunofluorescence staining of the structure with antibodies,so that no differentiation can be made with regard to the vulnerability of the respective cell types.
Differentin vivostudies showed that ischemia and reperfusion brain injury is mainly caused by inflammatory pathways. A study of Xiang and colleagues (Xiang et al., 2016) on brain injury following cardiac arrest features that one of the key pathways of cerebral injury is inflammation. This is in accordance with findings of Jou and co-workers (Jou et al.,2020) who postulates that inflammation and cytokines play a major role in the pathogenesis of post-cardiac arrest brain injury. Thereby anti-inflammatory agents may offer a beneficial post-treatment strategy. We focused on teriflunomide, an anti-inflammatory drug approved for treatment of relapsingremitting-multiple-sclerosis since 2013. Teriflunomides numerous modes of action are yet still under discussion.One effect of the active metabolite of teriflunomide,Leflunomide, is the reversible inhibition of the mitochondrial enzyme dihydroorotate dehydrogenase (Cherwinski et al.,1995; Bruneau et al., 1998). This enzyme is particularly active in proliferating cells, which is essential for thede novosynthesis of pyrimidines (e.g. cytidine triphosphate, thymidine triphosphate and uridine triphosphate) (Papadopoulou et al., 2012), thus exerting an cytostatic effect due to its importance for DNA- and RNA-synthesis as well as for production of phospholipids and bioactive second messengers(e.g. diacylglycerol, arachidonic acid (Herrmann et al.,2000)), which are important for inflammatory reactions(Gold and Wolinsky, 2011; Papadopoulou et al., 2012).Therefore teriflunomide acts cytostatic to proliferating Tand B-lymphocytes (Ringheim et al., 2013; Bar-Or, 2014).Furthermore is teriflunomide able to reduce the production of pro-inflammatory cytokines, like tumor necrosis factor-α and IL-17, via the Janus-tyrosine-kinases, especially JAK-1 and-3 (González-Alvaro et al., 2009; Papadopoulou et al., 2012).Additionally, Li and colleagues (Li et al., 2013) discovered that teriflunomide can act in a dihydroorotate dehydrogenaseindependent way by significantly decreasing the release of pro-inflammatory cytokines and chemokines from activated monocytes. It has been showed that the administration of teriflunomide decreases the proinflammatory cytokine secretion in microglia exposed to human immunodeficiency virus type 1-vector-transduced monocytic cells which is associated with reduced neurotoxicity and enhanced neuronal viability (Ambrosius et al., 2017). A series of experiments conducted by Prabhakara et al. (2018) examined the beneficial aspects of teriflunomide on experimental traumatic brain injury in rats. They demonstrated that teriflunomide is able to decrease inflammation and increases neurogenesis in the hippocampus. In their experiments with live animals they also displayed teriflunomide to be able to decrease the permeability of the blood-brain barrier, preventing edema and thus influx of inflammatory factors and cells, such as microglia and macrophages (Prabhakara et al., 2018). The studies of Wostradowski et al. (2016) suggest teriflunomide has anti-inflammatory properties and reduces microglial proliferation. This fact is confirmed by a recent publication by Lu et al. (2020). Lu and colleagues demonstrate in a mouse model of transient middle cerebral artery occlusion a positive effect of teriflunomide on neuroinflammation and also milder neurological deficits in mice treated with teriflunomide after transient middle cerebral artery occlusion (Lu et al., 2020).Thus, our results are consistent with new findings of these scientists.
It is known that ischemia and reperfusion injury of the brain is characterized by different phases. In the early phase,predominately oxidative stress disturbs mitochondria followed by activation of inflammasomes and finally complex and cellular inflammatory responses even in remote organs(Eltzschig and Eckle, 2011; Lin and Wang, 2016). It has to be taken into account, that our model does not differentiate between the early and late phases of reperfusion injury since every culture was constantly stopped on the second day after OGD. Nevertheless, we could clearly demonstrate beneficial effects of teriflunomide as a post-treatment drug after OGD.However, it has to be considered that Teriflunomide does not permeate the unimpaired blood-brain-barrier very well. It is estimated that only 1-2% of oral administered Teriflunomide actually reach the CNS (Tallantyre et al., 2008; Limsakun and Menguy-Vacheron, 2010; Wostradowski et al., 2016). So, the delivery to the actual tissue at risk after an ischemia might be problematic.
Organotypic slice cultures as well as oxygen-glucosedeprivation offer a well-established methodology to study the effect of an ischemic event on complex neurological structures. Here, we show for the first time a beneficial effect of teriflunomide on organotypic slice cultures of the hippocampus and cerebellum after an OGD by displaying a significant decrease in detectable PI-signal intensity, after application of the drug, compared to cultures subjected to OGD without a post-treatment. However, hippocampal slice cultures showed a higher vulnerability to ischemic conditions and a more sensitive response to teriflunomide compared to cerebellar slice cultures.
From a clinical point of view, the drug offers promising potential for a targeted treatment of ischemia and reperfusion injury after cardiac arrest. Further studies may proof a potential clinical benefit of teriflunomide in ischemia and reperfusion injury.
Acknowledgments:The authors gratefully acknowledge Anke Lodwig,Claudia Grzelak, and Anja Harbecke (Institute of Anatomy, Department of Cytology, Medical Faculty, Ruhr University Bochum, Bochum, Germany)for technical assistance, as well as Aja Lenz (Institute of Anatomy,Department of Cytology, Medical Faculty, Ruhr University Bochum,Bochum, Germany) for secretarial work. We acknowledge support by the Open Access Publication Funds of the Ruhr-Universität Bochum.
Author contributions:PG, TW, CT, HV, and VM contributed to the study conception and design. Material preparation, data collection and analysis were performed by AW, JR and VM. The first draft of the manuscript was written by AW, JR, HV, and VM and PG, TW, and CT commented on previous versions of the manuscript. All authors read and approved the final manuscript. HV and VM contributed equally to the study and share the senior authorship.
Conflicts of interest:The authors declare that they have no conflict of interest.
Financial support:None declared.
Institutional review board statement:According to current German and European legislation, the removal of organs or cells from vertebrates for scientific purposes is not considered an animal experiment if the animals have not been subject to surgical interventions or invasive treatments prior to sacrifice. Thus, euthanization of mice intended for the removal of brain tissue does not need an approval or permission by local or governmental authorities.
Copyright license agreement:The Copyright License Agreement has been signed by all authors before publication.
Data sharing statement:Datasets analyzed during the current study areavailable from the corresponding author on reasonable request.
Plagiarism check:Checked twice by iThenticate.
Peer review:Externally peer reviewed.
Open access statement:This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix,tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.